Study of PBI-0451 in Healthy Subjects.

NCT05011812 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

130

Enrollment

INDUSTRY

Sponsor class

Conditions

Covid19

Interventions

DRUG: PBI-0451 Dose 1
DRUG: PBI-0451 Dose 2
DRUG: PBI-0451 Dose 3
DRUG: PBI-0451 Dose 4
DRUG: Ritonavir
DRUG: Midazolam
DRUG: Placebo
DRUG: PBI-0451
DRUG: PBI-0451 Dose 5

Sponsor

Pardes Biosciences, Inc.